We describe a novel procedure for in situ hybridization that combines the use of digoxigenin-labeled oligonucleotide probes with an antibody enhancement step that can be performed on formalin-fured, paraffii-embedded tissues. Addition of a second antibody enhances the visibility of parathyroid hormone-related protein (PTHrP) mRNA expression from barely to highly discernible and interpretable, with virtually no nonspecific background expression. This technique has allowed visualization of PTHtP mRNA in normal human skin and epithelium-derived tumors. FI'HrP mRNA expression was confiined to the basal and spinous keratinocyte layers of skin. There was strong hybridization in the spinous keratinocyte layer and a low level of hybridization in the basal layer. An extensive panel of positive and negative controls included poly d(T) probe to indicate total mRNA present in the sections. Squamous cell carcinomas and basal cell carcinomas of the skin, from pathology
Introduction
Parathyroid hormone-related protein (PTHrP) was isolated and cloned from human cell lines derived from patients with humoral hypercalcemia of malignancy (HHM) (12, 14, 21) . Subsequently, PTHrP was localized in tumors from normocalcemic patients as well as in normal skin (1, 3, 9) . archives, were examined for the presence of PTHrP "A. The results tenected previous immunohistochemical studies, with every squamous cell carcinoma hybridizing strongly with the PTHrP probes. The basal cell carcinomas showed no expression of PTHrP "A, although the total mRNA signal was very strong. The localization of PTHrP mRNA in the tumors of the gynecological tract also reflected the immunohistochemical findings, with expression found in the squamous cell arcinomas but not in the adenocarcinomas. In situ hybridization with digoxigenin-labeled oligonucleotide probes and antibody enhancement has provided a sensitive, highly specific procedure for detection of PTHrP mRNA in tumors and normal tissue. ( J Hisrochem Cytochem 43: KEY WORDS: Parathyroid hormone-related protein; Human skin; Epithelial tumors; In situ hybridization; Digoxigenin; Antibody enhancement.
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skin and 20 of 21 adenocarcinomas were negative. Gynecological lesions have been examined for the presence of the PTHrP antigen and over 85 % of squamous cell carcinomas were positive, whereas only 13% of adenocarcinomas were positive (10,ll) . Squamous tumors are generally associated with the pathogenesis of HHM, but squamous gynecological tumors rarely cause this syndrome (15) even though the neoplasms possess the PTHrP antigen.
Ofthe reported studies of in situ hybridization of PTHrP mRNA (6, 16, 18, 19, 22) , all have employed radioactively labeled cDNA or riboprobes. In general, and in our experience with radioactive in situ hybridization (16, 18, 22) , nonspecific background radioactivity causes problems and the resolution is often less than ideal. Oligonucleotide probes are very specific but until now they have not been sensitive enough to detect PTHrP mRNA. Antibody enhancement has the potential to increase the sensitivity of an in situ hybridization technique, using the principles demonstrated in immunohistochemistry (20) and utilized in hybridization histochemistry with biotin-labeled (4) probes. We have employed antibody enhancement for in situ hybridization with digoxigenin-labeled probes on normal human skin and on epithelium-derived tumors of the skin and of the gynecological tract.
Materials and Methods
Samples. Normal skin samples were obtained with informed consent from healthy individuals undergoing facial plastic surgery. Tumor biopsy specimens were obtained from the Anatomical Pathology departments at the Repatriation Hospital and the Mercy Hospital for Women in the course of normal patient management. The biopsy specimens, 10 squamous cell and 10 basal carcinomas of the skm, together with 10 squamous cell carcinomas and 10 adenocarcinomas of the gynecological tract, were fixed in 10% neutral buffered formalin, processed, and embedded in paraffin. Sections 5 pm thick were cut on a Leitz 1515 microtome and adhered to slides treated with tissue adhesive (2% 3-aminopropyltriethoxysilane-acetone) (Sigma; St Louis, MO).
Oligonucleotide Probes. Three 33-mer sequences were synthesized on an Applied Biosystems Automated DNA Synthesiser Model 392: 5'd(TM GAG GCG GCG GCT GAG CCA CTC CAC CGA GCG) 3'; >'d('MG GAT GGA CTT CCC CCT GTC ATG GAG GAG CTG)3'; and 5'd(AAA TCG GAC GGG GTG GTT ClT TGT G'M GGG AGA) 3'. The three sequences are complementary to the regions of human PTHrP mRNA coding for the amino acid sequences PTHrP -12 to -2 (JD33A). 6 to 16 (JD33B), and 50 to 60 UD2), respectively.
Labeling. All solutions used for probe preparation, pre-hybridization, and hybridization were treated with 0.02 % DEPC (diethylpyrocarbonate; Sigma). The probes were labeled at the 3' end with terminal deoxynucleotidyl transferase. The reaction mixture consists of tailing buffer (100 mM potassium cacodylate, pH 7.2, 2 mM CoC12, 0.2 mM DlT) (Gibco; Detroit, MI) with 40 units of terminal transferase (Gibco), 1 pg PTHrP probe, and 25 nmoles of digoxigenin-ll-dUTP (Boehringer Mannheim; Mannheim, Germany). The volume was made up to 20 pl with water. The reaction mixture was incubated at 37'C for 2-18 hr and was stopped with the addition of 2 pI of 200 mM Nal EDTA. The tailed oligonucleotide was precipitated with 2.5 p1 of 4 M LiCl and 75 pI of pre-chilled 100% ethanol. After mixing well, the mixture was chilled at -7O'C for at least 30 min. The mixture was centrifuged at 12,000 x g for 10 min and the pellet washed with 50 pl of cold 70% (vlv) ethanol. After removing the ethanol the pellet was dissolved in 100 pl of sterile, redistilled water and stored at -20°C.
In Situ Hybridization. The in situ hybridization technique was based on that of McHale et al. (manuscript submitted for publication). Briefly, sections were dewaxed in two changes of xylene, followed by two washes in 100% ethanol and two washes in 90% ethanol. The sections were washed in water for 5 min. then two 5-min washes in PBS. This was followed by a 15-min incubation of the slides in 0.3% Triton X-100 (Sigma) before another two 5-min rinses in PBS. They were then post-fixed in 4% paraformaldehyde (BDH; Poole, UK) for 5 min and washed twice for 5 min in PBS. Sections were placed in pre-hybridization buffer [25% deionized formamide (BDH)/3 x SSC) for 1 hr at room temperature (RT). Hybridization buffer (20 ~1 ) containing 10 ng of digoxigenin-labeled F'THrP probe was applied to the appropriate section. The hybridization buffer consisted of 3 x SSC, 25% deionized formamide, 0.1% polyvinylpyrrolidone (Sigma), 0.1% Ficoll (Sigma), 1% bovine serum albumin (Sigma), 250 pglml salmon sperm DNA (Sigma), 250 pglml yeast tRNA (Boehringer Mannheim). The sections were covered with glass coverslips and hybridization was carried out in a humid chamber for 2-18 hr at RT. Coverslips were removed in 4 x SSC and sections washed for 15 min each in two changes of 3 x SSC. They were then washed for 5 min in a modified =is-buffered saline (TBS) consisting of 0.1 M Tris (BDH). 0.15 M NaCl (BDH), pH 7.5. Antibody Enhancement. After the wash in TBS the sections were flooded with sheep anti-digoxigenin antiserum (Boehringer Mannheim) diluted 1:250 in TBS with 5% normal rat serum. They were incubated in a humid chamber for 1 hr at RT, after which they were washed three times for 5 min in TBS. Alkaline phosphatase-linked donkey anti-sheep immunoglobulins (Boehringer Mannheim) were applied to the sections at a dilution of 1:500 in TBS with 5 % normal rat serum, for 1 hr at RT. The sections were washed three times for 5, min in TBS, followed by one 5-min wash in 0.1 M Tris, 0.1 M NaCI. 0.05 M magnesium chloride, pH 9.5. The reaction was visualized with 225 pglml4-nitrobIue tetrazolium chloride (NBT; Boehringer Mannheim) in 70% dimethyl formamide and 175 pglml5-bromo-4-chloro-3-indolyl-phosphate (BCIP; Boehringer Mannheim) in 100% dimethyl formamide as substrates in 0.1 M Tris, 0.1 M NaCI, 0.05 M magnesium chloride, pH 9.5, with 10 mM levamisole (Sigma) to block endogenous alkaline phosphatase activity in the tissues. The sections were counterstained with Mayer's hematoxylin (Sigma) and mounted with Aquamount (Gurr; Poole, UK). Controls 1.
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7. Sections were processed as described above but in the absence of labeled probe. Sections were subjected to RNAse A (Boehringer Mannheim) treatment (100 pglml-200 pglml in 2 x SSC for 90 min at 37°C) before hybridization. An initial hybridization was carried with unlabeled probe in a threefold excess, followed by incubation with labeled probe. A positive control of normal human skin was included in each experiment. Sections were hybridized with a poly d(T) (20-mer) probe (Pharmacia; Uppsala, Sweden) to assess the total RNA in the sections (18) . Sections were hybridized with a poly d(A) (20-mer) probe (Pharmacia) to act as a sense control for the poly d(T) probe. Sections were hybridized with a "nonsense" probe. This was a reverse anti-sense probe (33-mer) to the constant region of the K-i"unoglobulin light chain (a generous gift from Dr. Janice Roy&, Department of Pathology, University of Sheffield, UK).
Immunohistochemistry. Immunohistochemistry was performed for the PTHrP antigen (3) with a rabbit antibody directed to the first 16 amino acids of the protein (R1133). This antibody does not crossreact with parathyroid hormone (2,3) and positive and negative controls were carried out as previously described (3).
Results
PTHrP mRNA visualized by oligonucleotide probe JD2 and antibody enhancement in normal skin is shown in Figure 1A . There was strong hybridization in the spinous keratinocyte layer and a low level of hybridization in the basal layer. There was no detectable hybridization in the terminally differentiated granular or cornified layers of the epidermis. PTHrP mRNA was present in spinous-granular keratinocytes, cells characterized by fewer keratohyalin granules than are found in the granular cells ( Figure 1A ). PTHrP mRNA also was localized to the inner root sheath of hair follicles and sweat glands (not shown). The pattern of expression was exactly the same for each of the PTHrP probes as for the probe JD2 (not shown). PTHrP mRNA in normal skin visualized without antibody enhancement is shown in Figure 1B . The hybridiza- tion signal seen in all of the layers of the epidermis and the dermis was nonspecific background signal. No specific signal was obtained in the absence of probes (not shown). In the RNAse control there was no detectable expression of PTHrP mRNA (Figure IC) . Preincubation with unlabeled probe abolished the signal in the skin (not shown). No signal was obtained when the sections were hybridized with the "nonsense" probe (not shown). Hybridization of the skin with poly d(T) showed intense hybridization of the enure viable portion of the epidermis (Figure ID) , indicating that mRNA is present throughout.
Ten squamous cell carcinomas and 10 basal carcinomas of the skin were examined for the presence of PTHrP mRNA. The location of the mRNA reflected the results obtained from the PTHrP immunohistochemistry on these sections; an example of a squamous cell carcinoma hybridized for PTHrP mRNA (Figure E) and a section of the same tumor stained for the PTHrP antigen reflected the results of the in situ hybridization (not shown). All three PTHrP oligonucleotide probes hybridized to the cells within the squamous cell tumors (not shown), and treatment with RNAse abolished this hybridization signal (not shown). In controls where the probe was absent from the hybridization buffer, or when the "nonsense" probe was substituted, no signal was seen (not shown). The basal cell carcinomas showed no hybridization to any of the PTHrP probes, and the spinous keratinocyte layer of the overlying skin appeared to hybridize PTHrP mRNA at a lower level compared with normal skin (Figure lF) . The poly d(T) probe demonstrated that the basal tumor cells did contain mRNA ( Figure 1G ).
Gynecological tumors previously examined for the F'THrP antigen (11) were included in this study. All 10 squamous tumors were known to be positive for the PTHrP antigen, and the 10 adenocarcinomas were known to be negative for PTHrP from immunohistochemical studies. Every one of the squamous carcinomas expressed PTHrP mRNA, which was localized within the neoplasm and did not involve the stroma and keratin pearls ( Figure ZA) . The other two PTHrP probes UD2, JD33A) hybridized in exactly the same pattern as provided by JD33B (not shown). No specific signal was obtained with the poly d(A) probe (not shown), thus verdying the specificity of the hybridization with the PTHrP probes. Again, no signal was obtained when no probe was present or when the sections were treated with RNAse (Figure 2B) . The adenocarcinomas showed no expression of PTHrP mRNA (Figure 2C) , but the poly d(T) probe did hybridize strongly (Figure 2D ).
Discussion
This is the first report of in situ hybridization of PTHrP mRNA performed with digoxigenin-labeled oligonucleotide probes and antibody enhancement. Addition of a second antibody enhanced PTHrP mRNA expression from barely to highly discernible and 
interpretable, with virtually no nonspecific background expression.
This technique should allow other mRNAs with very low levels of expression to be visualized with non-radioactive probes.
The localization of PTHrP mRNA in epithelial tumors reflects the pattem of localization obtained by immunohistochemical detection of the PTHrP antigen. In normal epidermis, PTHrP mRNA was expressed only in the spinous and basal layers. No PTHrP mRNA was evident in the fully differentiated granular and cornified layers. In Figure 1A there was an area where spinous keratinocytes are ddferentiating into granular with the process incomplete, and PTHrP mRNA was present in those cells. The results were consistent for all three PTHrP probes. The level of hybridization in the basal layer was much lower than that seen in the spinous keratinocyte layer but suggests that some PTHrP synthesis may occur here, even though the protein has not been detected in the basal layer in previous immunohistochemical or hybridization histochemical studies carried out by ourselves and others (3, 5, 9, 13, 19) . This hybridization of PTHrP mRNA in the basal layer is in contrast to the lack of hybridization to basal cell carcinomas, neoplasms that consist entirely of basal cells.
The finding that PTHrP mRNA is not detectable in the cornified and granular layers is consistent with several previous immunohistochemical studies localizing the antigen in skin (3,9,13) but contrasts with the findings of Atillasoy et al. The only in situ hybridization study that has examined epidermis was that of Senior et al. (19) , utilizing radioactive probes for PTHrP in developing fetal rat. They found that the hybridization pattern in the keratinocyte layer correlated with the immunohistochemical findings of Danks et al. The in situ hybridization of PTHrP mRNA in gynecological tumors with non-radioactive probes and antibody enhancement reflects the immunohistochemical localization of the PTHrP antigen (11) . None of the adenocarcinomas hybridized with any of the PTHrP probes, which accords with their negativity for the PTHrP antigen. Previous studies using Northern analysis and in situ hybridization have found PTHrP mRNA in adenocarcinomas of the breast (6,7) and lung (6). As the poly d(T) hybridization indicates that there is mRNA present in the sections, PTHrP mRNA may be present but below the level of detection of the in situ hybridization technique. It could be that formalin fixation diminishes the PTHrP mRNA level below the sensitivity of the in situ technique.
The squamous gynecological tumors that hybridized with the three PTHrP probes were all positive for the PTHrP antigen. The localization of the PTHrP mRNA within the tumor and the sparing of the keratin pearls and stroma mirror the findings of PTHrP immunohistochemical studies in gynecological tumors by Mackenzie et al. (11) and Kitazawa et al. (10) . These tumors are very uncommonly associated with hypercalcemia (15) . PTHrP produced in these gynecological tumors may serve a paracrine function.
Localization of PTHrP mRNA in the squamous cell carcinomas of the skin again reflected previous immunohistochemical studies (3, 9) in which PTHrP antigen was present in the spinous keratinocytes of the tumors. The presence of spinous keratinocytes is one of the differentiating pathological features of squamous cell carcinoma.
On the other hand, basal cell carcinomas of the skin did not hybridize with any of the PTHrP probes. Previous PTHrP immunohistochemistry of these lesions found that the antigen was not present (3). The poly d(T) probe hybridized strongly to all 10 biopsy specimens, indicating that mRNA was preserved and present in the sections. The amount of FTHrP mRNA could be below the sensitivity of the in situ hybridization, but to date there is no evidence for the expression of either mRNA for PTHrP or the protein itself in these tumors.
In situ hybridization with non-radioactive probes and antibody enhancement has demonstrated PTHrP gene expression in normal human adult skin and epithelial tumors, suggesting that it will be a useful technique for rapid and reliable investigation of human tissue samples. related protein in human lung cancer and normal tissue with a newly developed monoclonal antibody. Cancer 67984, 1991
